- Home
- BSBK vs ALEC Comparison
BSBK vs ALEC Comparison
Compare BSBK & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSBK
- ALEC
- Stock Information
- Founded
- BSBK 1893
- ALEC 2013
- Country
- BSBK United States
- ALEC United States
- Employees
- BSBK N/A
- ALEC N/A
- Industry
- BSBK Banks
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BSBK Finance
- ALEC Health Care
- Exchange
- BSBK Nasdaq
- ALEC Nasdaq
- Market Cap
- BSBK 109.5M
- ALEC 124.0M
- IPO Year
- BSBK N/A
- ALEC 2019
- Fundamental
- Price
- BSBK $8.55
- ALEC $1.50
- Analyst Decision
- BSBK
- ALEC Hold
- Analyst Count
- BSBK 0
- ALEC 9
- Target Price
- BSBK N/A
- ALEC $3.40
- AVG Volume (30 Days)
- BSBK 6.1K
- ALEC 4.6M
- Earning Date
- BSBK 10-31-2025
- ALEC 11-06-2025
- Dividend Yield
- BSBK N/A
- ALEC N/A
- EPS Growth
- BSBK N/A
- ALEC N/A
- EPS
- BSBK N/A
- ALEC N/A
- Revenue
- BSBK $14,709,306.00
- ALEC $81,130,000.00
- Revenue This Year
- BSBK N/A
- ALEC N/A
- Revenue Next Year
- BSBK N/A
- ALEC $290.64
- P/E Ratio
- BSBK N/A
- ALEC N/A
- Revenue Growth
- BSBK 16.23
- ALEC 46.77
- 52 Week Low
- BSBK $6.59
- ALEC $0.87
- 52 Week High
- BSBK $9.50
- ALEC $6.14
- Technical
- Relative Strength Index (RSI)
- BSBK 34.60
- ALEC 26.92
- Support Level
- BSBK $8.57
- ALEC $1.33
- Resistance Level
- BSBK $9.08
- ALEC $1.60
- Average True Range (ATR)
- BSBK 0.21
- ALEC 0.21
- MACD
- BSBK -0.03
- ALEC -0.21
- Stochastic Oscillator
- BSBK 5.17
- ALEC 8.21
About BSBK Bogota Financial Corp.
Bogota Financial Corp is a New Jersey-based bank. It offers personal and business banking services such as savings, certificates of deposits, online banking, loans, and many more. The Bank generally grants residential, commercial, and consumer loans to, and accepts deposits from customers in New Jersey.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.